Can I get it?
Not for this use. Ipamorelin has no EU authorisation for it, so it cannot be prescribed or dispensed here for that purpose.
Why buying it online is risky
Ipamorelin
Ipamorelin.
Not something we can prescribe. Our doctors can review your case for an EU-approved treatment instead.
Full refund if a review is not approved
NOT AVAILABLE TODAY
Hi-Doctor does not prescribe Ipamorelin.
Our licensed doctors currently focus on three areas with solid clinical evidence and a clear EU regulatory framework. We extend the catalogue as specialists join and regulation allows. Ipamorelin is outside the current scope.
Buying Ipamorelin online without a valid prescription carries counterfeiting and toxicity risks. Always consult a licensed healthcare professional.
IN PLAIN TERMS
What Ipamorelin is, and how to get treatment
Ipamorelin is a laboratory-made peptide that acts on the ghrelin receptor in the pituitary gland, prompting the body to release a short burst of its own growth hormone. A pharmaceutical company tested it for recovery of bowel function after surgery; it was never approved for any use, in the European Union or anywhere else, so no doctor can prescribe it. It is now sold online for muscle gain and "anti-ageing" — uses for which no completed trial result has ever been published. Those vials are supplied as research chemicals made outside medicines manufacturing rules, so their contents and purity cannot be verified.
Ipamorelin has no EU marketing authorisation for this use. It may be an approved medicine for something else, or approved in another country — but not something a doctor here can prescribe for this.
What can I take instead?
Our doctors review every option and recommend what fits your history and goals.
What do the studies show?
Every trial behind Ipamorelin is listed below with its registry number, how many people took part, and whether the results are peer-reviewed or a company announcement.
Jump to the studiesWHAT WE DO COVER
If your question fits one of these three areas, a licensed doctor reviews it in less than 2 hours on average for €35.
TREATMENTS
Three categories, one process.
Choose what fits. The journey is identical.
ONGOING PLANWeight loss
A medical consultation on your weight goal. Treatment if appropriate.
€25/month28-day treatment cycle
Explore weight lossONE-OFFSexual health
An absolutely discreet consultation for intimate concerns.
€35 one-offFull refund if not approved
Explore sexual healthONGOING PLANHair growth
Medical assessment and tailored treatment for hair loss.
€15/monthBilled €45 every 90 days
Explore hair growthLicensed EU doctors
Doctor review in less than 2 hours on average
50,000+ patients served
Secure patient account
VERIFIED EVIDENCE
Ipamorelin: evidence and regulatory guide.
WHAT IT IS
How it works
A laboratory-made peptide that switches on the ghrelin receptor in the pituitary gland, prompting a short burst of the body's own growth hormone.
- GHS-R1a (ghrelin receptor)
DEVELOPMENT STAGE
Not marketed in the EU
Trial register2 registered trials
Every NCT identifier links to its ClinicalTrials.gov record. A readout is not the same as peer-reviewed publication.
| TRIAL / NCT | POPULATION | PARTICIPANTS | STATUS | READOUT / COMPLETION |
|---|---|---|---|---|
| Phase 2 study of ipamorelin for management of post-operative ileusNCT00672074 | Adults recovering from bowel surgery | 117 | Read out | 2009-12-01 |
| Phase 2 dose-finding study of ipamorelin for recovery of gastrointestinal function after bowel resectionNCT01280344 | Adults following small or large bowel resection with primary anastomosis | 320 | Read out | 2013-06-01 |
Sources
Last reviewed 2026-07-27
- FDA — Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks (Ipamorelin acetate, 503B category 2, added 29 September 2023; page current as of 22 April 2026)
- ClinicalTrials.gov — NCT01280344, phase 2 dose-finding study of ipamorelin (Helsinn Therapeutics), 320 participants, completed; no results posted
- ClinicalTrials.gov — NCT00672074, phase 2 study of ipamorelin for post-operative ileus, 117 participants, completed; no results posted
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance — Sports Med 2026
- EMA — medicines database (no authorised EU medicine contains ipamorelin; checked against the EMA medicine list generated 27 July 2026)
- ClinicalTrials.gov · NCT00672074
- ClinicalTrials.gov · NCT01280344
NAMED SAFETY SIGNALS
What has been reported with Ipamorelin.
Serious adverse events reported with intravenous use
The US Food and Drug Administration states that "a study published in literature identified serious adverse events including death when ipamorelin was administered intravenously for improving gastric motility".
Unknown safety by other injected routes
The FDA states it "has not identified safety-related information regarding ipamorelin acetate via certain other injectable routes of administration" and therefore "lacks sufficient information to know whether the drug would cause harm if administered to humans via those routes".
Placed on the FDA's safety-risk list
Ipamorelin acetate was added on 29 September 2023 to category 2 of the FDA's interim bulk drug substances policy — substances that may present significant safety risks — and remains listed there.
No published efficacy result
Two company-run phase 2 trials completed in 2009 and 2013; neither posted results to the trial registry, and ipamorelin was never approved for any indication.
UNAPPROVED PRODUCTS ONLINE
Why buying Ipamorelin online is not a shortcut.
No doctor in the EU can prescribe it for this use — including ours. It may be authorised in another country, or for a different condition.
Check the EU common logo
A legitimate online pharmacy in the EU must display the common logo linked to its national register. The logo is a verification check; it cannot make an unapproved medicine legal.
How the EU common logo worksIpamorelin is a molecule frequently searched online; it does not currently fall within Hi-Doctor's clinical scope.
Compound: IpamorelinOutside current scopeNot prescribed on Hi-Doctor
WHAT TO KNOW
Ipamorelin in context.
Hi-Doctor focuses today on three areas — hair growth, weight management and sexual health — and Ipamorelin sits outside that scope. We can't review your case for this molecule on the platform.
The doctor reviews your questionnaire, rules out contraindications and explains the available options clearly. If your case is not eligible, the doctor tells you at no extra cost and the €35 one-off consultation fee is refunded.
HOW HI-DOCTOR WORKS
Your consultation step by step.
1) You fill in the online medical questionnaire in about 4 minutes.
2) An EU-licensed doctor reviews your case in less than 4 hours on average.
3) If appropriate, the doctor issues a prescription electronic prescription valid at any EU pharmacy under EU Directive 2011/24/EU.
4) You collect the medication at your nearest pharmacy and follow up through the private chat in your account — no WhatsApp, no SMS.
REVIEWED BY HI-DOCTOR LICENSED PHYSICIANS · EDUCATIONAL CONTENT, NOT A SUBSTITUTE FOR A CONSULTATION
HOW IT WORKS · 5 STEPS
Five steps. No waiting room.
From the online consultation to ongoing follow-up — without leaving home.
- 5 minutes
Start your online visit
Answer a 5-minute health questionnaire from home.
- Less than 2 hours
A doctor reviews your case
A licensed doctor reviews your answers and replies personally.
- Refund guarantee
Review and payment
If not approved, we refund your €35 one-off in full.
- EU pharmacies
Collect treatment from the pharmacy
Collect it at any EU pharmacy with your e-prescription.
- 4-week check-in
Ongoing support
Private chat, 4-week check-in, simple prescription renewal.
NOTIFY ME
We'll tell you when we add new treatments.
We only use your email for this notification. You can opt out at any time.
FREQUENTLY ASKED QUESTIONS